Evidence map›Paper›PMID 38888305›Full record

ArticleJournal of clinical microbiology2024

Performance evaluation of the Panbio COVID-19/Flu A&B Panel for detection of SARS-CoV-2, influenza A, and influenza B antigens using mid-turbinate nasal swabs.

Shao-Hua Yu, Keun-Ju Kim, Chien-Chang Lee, Yanely Pineiro Puebla, Gelza Mae A Zabat, Hong-Mo Shih, Po-Ren Hsueh

Abstract readEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shao-Hua YuDepartment of Emergency Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Keun-Ju KimDepartment of Laboratory Medicine, Korea University College of Medicine, Seoul, South Korea.
Chien-Chang LeeDepartment of Emergency Medicine, National Taiwan University, Taipei, Taiwan.
Yanely Pineiro PueblaPalm Springs Community Health Center, Palm Springs, California, USA.
Gelza Mae A ZabatHealth Cube Medical Clinics, Philippines, Philippines.
Hong-Mo ShihDepartment of Emergency Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Po-Ren HsuehDepartment of Laboratory Medicine, China Medical University Hospital, School of Medicine, China Medical University, Taichung, Taiwan.ORCID 0000-0002-7502-9225

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Panbio COVID-19/Flu A&B Panel (Abbott) is an IMPORTANCE: The Panbio COVID-19/Flu A&B Panel is a suitable rapid test for detecting COVID-19 and influenza in symptomatic subjects across diverse global populations, exhibiting high sensitivity. The assay achieved a sensitivity of 94.0% in samples with Ct ≤24 for COVID-19 and 92.6% in samples with Ct ≤30 for influenza A and B.

Indexed as

Antigens, ViralCOVID-19Influenza A virusInfluenza B virusInfluenza, HumanSARS-CoV-2Sensitivity and SpecificityAdolescentAdultAgedAged, 80 and overChildChild, PreschoolCOVID-19 TestingFemaleHumansAntigens, Viralcobas SARS-CoV-2 & Influenza A/B qualitative assayCOVID-19Panbio COVID-19/Flu A&B PanelSARS-CoV-2sensitivityspecificity

Identifiers

PMID38888305
PMCPMC11250729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.